SBIA
LABU icon

Sheaff Brock Investment Advisors’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Sheaff Brock Investment Advisors’s Portfolio LABU Stock Details LABU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-500
Closed -$49.1K – 513
2023
Q1 		$49.1K Buy
+500
New +$67.8K ﹤0.01% 502

Other funds holding LABU

Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
GS
GTS Securities New York $2.83B AUM 21.76% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wolverine Trading
Wolverine Trading Chicago, Illinois $139B AUM 31.83% 1-Year Est. Return
EFG
Ethos Financial Group King Of Prussia, Pennsylvania $1.37B AUM 19.43% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Sheaff Brock Investment Advisors's LABU Position: Q1 2025 in Review

Sheaff Brock Investment Advisors held its Direxion Daily S&P Biotech Bull 3X ETF (LABU) position steady in Q1 2025 at 4,000 shares worth $244K. The position accounts for 0.02% of the portfolio, ranked #364.

Sheaff Brock Investment Advisors first reported a position in LABU in Q1 2023 and has held it in 7 quarters since. The position peaked at $531K in Q1 2024. 34 funds tracked by Wall St. Rank hold LABU as of Q1 2025.

  • Sheaff Brock Investment Advisors held 4,000 shares of Direxion Daily S&P Biotech Bull 3X ETF worth $244K as of Q1 2025.
  • Sheaff Brock Investment Advisors left its Direxion Daily S&P Biotech Bull 3X ETF share count unchanged in Q1 2025.
  • Direxion Daily S&P Biotech Bull 3X ETF made up 0.02% of Sheaff Brock Investment Advisors's portfolio in Q1 2025, its #364 holding.
  • Sheaff Brock Investment Advisors first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q1 2023 and has held it in 7 quarters since.
  • Sheaff Brock Investment Advisors's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $531K in Q1 2024.
  • 34 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q1 2025.

Based on Sheaff Brock Investment Advisors's 13F filing for Q1 2025, filed 7 May 2025.